The effect of equine herpesvirus type 4 on type-I interferon signaling molecules.

The research studies the impact of Equine herpesvirus type 4 (EHV-4) on molecules of type-I interferon (IFN) signaling in equine endothelial cells (EECs). It particularly highlights EHV-4’s influence on the expression and function of pivotal IFN signaling molecules, with less severe interference compared to EHV-1, potentially contributing to its less pathogenic nature.

Understanding EHV-4 and its Impact on IFN Signaling

• The study focuses on EHV-4, a virus that causes respiratory disease in horses. While the virus is mildly pathogenic, it is a common ailment among horses across the globe.
• Earlier research suggested that EHV-4, unlike EHV-1, does not strongly induce type-I IFN and doesn’t substantially suppress its response. This difference becomes especially noticeable in the later stages of infection.

Investigating EHV-4’s Impact on Type-I IFN Signaling Molecules

• Researchers examined how EHV-4 infection affects type-I IFN signaling molecules in EECs after 3, 6, and 12 hours of infection.
• Findings indicated that EHV-4 neither induced nor suppressed the expression of TLR3 and TLR4 in EECs at any given time points.
• However, the virus was found to induce varying amounts of IRF7 and IRF9 in EECs. There was no evidence of a suppressive impact on these key transcription factors affecting IFN-α/β induction.

EHV-4’s Influence on the Phosphorylation of STAT1/STAT2

• Interestingly, EHV-4 was found to meddle with the phosphorylation of STAT1/STAT2 at 3 and 6 hours post-infection (hpi), but to a lesser extent at 12 hpi.
• An active EHV-4 viral gene expression is necessary for the virus to suppress STAT1/STAT2 phosphorylation in the early stages of infection.
• At least one or more early viral genes of EHV-4 participated in the suppressive impact observed on STAT1/STAT2 phosphorylation at early infection stages.

Relevance of the Findings

• The lack of significant down-regulation of key type-I IFN signaling molecules by EHV-4 may explain the virus’s milder pathogenesis in comparison with EHV-1.
• Better understanding of this natural, less-severe infection mechanism could be instrumental in devising strategies to control future disease outbreaks.